ClinicalTrials.Veeva

Menu

Screening of Patients With Rheumatoid Arthritis for Interstitial Lung Disease

P

Polyclinic of the Hospitaller Brothers of St. John of God, Budapest

Status

Enrolling

Conditions

Interstitial Lung Disease
Rheumatoid Arthritis

Study type

Observational

Funder types

Other

Identifiers

NCT05391100
IV/2683-1/2022/EKU

Details and patient eligibility

About

The quantitative and qualitative analysis of RA lung involvement in the Hungarian population

Full description

Interstitial lung disease (ILD) accounts for a significant proportion of mortality and morbidity in rheumatoid arthritis (RA). The aim of this prospective longitudinal study is to asess the interstitial lung involvement in Hungarian rheumatoid arthritis patients. Laboratory markers, X-ray based imaging methods, pulmonological functional tests, QOL questionnaire and sleep quality assessement questionnaire are used to estimate the interstitial lung disease. Also smaller cross-sectional studies about the imaging parameters and a national register is planned to be created based on these data.

Enrollment

500 estimated patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis of RA

Exclusion criteria

  • pregnancy, breastfeeding
  • previous diagnosis of ILD, lung cancer, registered lung infection in the last 2 months

Trial contacts and locations

3

Loading...

Central trial contact

Kinga Fritsch, MD; Judit Majnik, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems